Pharma Blog

/Pharma Blog
Pharma Blog 2018-02-26T09:29:08+00:00

PHARMA/BIOTECH

BASIC GMP, GMP Enforcement, Quality / CMC Guidance, and More…

GET YOUR FREE PEER BENCHMARK
  • Warning Letters

Week of August 5th 2018 | FDA Sent These Warning Letters to Pharma Companies

August 17th, 2018|

This week the FDA published 4 warning letters (3 to seafood companies and 1 to an API manufacturer - Les Produits Chimiques B.G.R. Inc).  We cover the latter below.

  • Invisible Ink

FINAL Part 3: Invisible Ink in GLP and GCP Research

August 14th, 2018|

“I can’t promise success, but I can tell you I’ve been successful most of the time when I walk a scientist through their process. To that end, I make the following proposal, which I hope will start a conversation here and which can be continued with your company and with your service providers.”

  • A New FDA Model

The New FDA GMP Inspection Model

August 13th, 2018|

While the drug GMPs haven’t changed much, if at all, in recent years, the FDA is planning for significant changes in how drug GMP inspections are scheduled and conducted. Last year, the FDA made available a description of their new operating model that will ensure integration of review and inspection activities for human drugs. This post dives deep into this model – including new timelines for those of us in the drug industry.

708, 2018

Part 2: Invisible Ink in GLP and GCP Research

August 7th, 2018|Categories: Biopharma / Pharma, CGMP, FDA Enforcement Trends, FDA Inspections, FDA Warning Letters, Medical Devices|

“When I started in the industry back in 1990, I was a statistical programmer. While none of us used the phrase ‘data integrity,’ the way we worked helped ensure data integrity.” This post dives deep into these questions: What game changing regulatory action happened in 1997? Why do we validate computer systems? Are there any regulatory provisions for draft GLP or draft GCP data?

208, 2018

The Easy Way to Research Your Inspector

August 2nd, 2018|Categories: Biopharma / Pharma, CGMP, FDA Inspections, FDA Warning Letters, Food, Form FDA 483, FSMA, Medical Devices|

When the FDA notifies you of an upcoming inspection, sometimes you only have minutes to prepare. You need information, and you need it fast. Most companies start with a Google search or call their colleagues to get information about their inspector. But with FDAzilla, you have more than anecdotes. You have real statistics. In this post, we will walk through an FDAzilla inspector profile — a snapshot of the inspection and citation history of one of the 4,000+ FDA inspectors in our database.